Corporate Banner
Satellite Banner
Informatics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Scale-up Systems and ScienView Team Up on Process Development

Published: Tuesday, May 14, 2013
Last Updated: Tuesday, May 14, 2013
Bookmark and Share
The developers of DynoChem® aim to accelerate process development in Chinese pharmaceutical industry.

Scale-up Systems Ltd. announced it has entered into a multi-year agreement with ScienView Co. Ltd. to provide DynoChem® software, training and process development support services to the Chinese pharmaceutical industry.

The motivation behind the agreement is to provide a dedicated local presence to help Chinese users to obtain maximum value from DynoChem’s tools. The initial team in the Beijing and Shanghai offices will be led by Dr. Jinjun Wang for Training & Technical Support and Jack Ma on the Business side.

According to Scale-up Systems CEO Dr. Joe Hannon, “We have been looking for a partner in China that, like our company, specialises in working with and understands the needs of the pharma and life sciences industry. We are therefore delighted to be working with ScienView.”

Scale-up Systems COO Dr. Steve Hearn said “What made ScienView stand out to us was the value it placed on hiring high quality training and support staff across multiple domains.”

ScienView’s Vice President of Informatics Services, Dr. Zhen Wang stated, “Many of our clients are pharmaceutical, chemical or CRO companies, and they are delighted to know that DynoChem will be provided to them along with our top-quality support. With the rapidly increasing R&D investments in China, businesses here also face significant challenges on managing costs and reducing pollution. DynoChem is an excellent tool to help them achieve these goals and is complementary to our products and services.”

Jack Ma, Business Development Manager for ScienView, added that “as the founder of the Shanghai Scientific Informatics Salon, a technical networking forum for big pharma, CRO and chemical companies as well as academics, ScienView finds that scientists and engineers here are very interested in new techniques and tools that can be applied successfully to their work and can be effectively supported by a local team.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,600+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Applying Deep Learning to Drug Discovery
Researchers train deep neural networks to predict the therapeutic use of large number of multiple drugs using gene expression data obtained from high-throughput experiments on human cell lines.
Advancing Protein Visualization
Cryo-EM methods can determine structures of small proteins bound to potential drug candidates.
Gene Expression Controls Revealed
Researchers have modelled every atom in a key part of the process for switching on genes, revealing a whole new area for potential drug targets.
Making Genetic Data Easier to Search
Scripps team streamlines biomedical research by making genetic data easier to search.
Monovar Drills Down Into Cancer Genome
Rice, MD Anderson develop program to ID mutations in single cancer cells.
It’s Now Easier To Go With The Flow
Rice University tool simplifies comparison of flow cytometry data for laboratories.
Making Precision Medicine a Reality
Researchers are one step closer to understanding the genetic and biological basis of diseases like cancer, diabetes, Alzheimer’s and rheumatoid arthritis – and identifying new drug targets and therapies.
New Database for Sharing MS Clinical Trial Data
A new database containing nearly 2500 patient records from the placebo arms of nine multiple sclerosis (MS) clinical trials is now available for research by qualified investigators.
‘Precision Prevention’ for Colorectal Cancer
New risk prediction model — not yet ready for clinical use — incorporates genetic, lifestyle and environmental risk factors.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,600+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!